Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perfluorocarbon may improve biosensor accuracy:

This article was originally published in Clinica

Executive Summary

Synthetic Blood International has received a notice of allowance on a US patent application covering the use of a perfluorocarbon emulsion as an O(2) reservoir in a biosensor. O2 is a critical substrate for most biosensors, says the Costa Mesa, California firm, which is developing an implanted glucose biosensor for monitoring diabetic patients. Because O2 levels are typically very low in tissue, it is believed that the a perfluorocarbon emulsion will increase available oxygen and improve accuracy in low-oxygen biosenor applications.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT071513

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel